CHINA PHARMA HOLDINGS, INC. Accrued Salaries, Current
CHINA PHARMA HOLDINGS, INC. (CPHI) had Accrued Salaries, Current of $1.26 million as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Notes › Accounts Payable and Accrued Liabilities, Current › Employee-related Liabilities, Current
us-gaap:AccruedSalariesCurrent · last filed 2024-11-13
- 2024-09-30: Accrued Salaries, Current $1.26M.
- 2024-06-30: Accrued Salaries, Current $1.25M.
- 2023-12-31: Accrued Salaries, Current $1.24M.
- 2023-09-30: Accrued Salaries, Current $963.51K.
| Period end | Accrued Salaries, Current |
|---|---|
| 2024-09-30 | $1.26M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.25M 10-Q · filed 2024-08-14 |
| 2023-12-31 | $1.24M 10-Q · filed 2024-11-13 |
| 2023-09-30 | $963.51K 10-Q · filed 2023-11-13 |
| 2022-12-31 | $951.51K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |